Faye - Dissemin

Language
Login

All papers authored by Faye

This paper was not found in any repository, but could be made available legally by the author.

2021 Faye A. Sharpley

ORCID

, Richa Manwani, Aviva Petrie, Shameem Mahmood, Sajitha Sachchithanantham, Helen J. Lachmann, Ana Martinez De Azcona Naharro, Julian D. Gillmore, Carol J. Whelan, Marianna Fontana, Oliver Cohen, Philip N. Hawkins

ORCID

, Ashutosh D. Wechalekar

Autologous stem cell transplantation vs bortezomib based chemotheraphy for the first‐line treatment of systemic light chain amyloidosis in the UK

Upload

This paper is made freely available by the publisher.

2019 Faye A. Sharpley

ORCID

, Aviva Petrie, Shameem Mahmood, Sajitha Sachchithanantham, Helen J. Lachmann, Julian D. Gillmore, Carol J. Whelan, Marianna Fontana, Ana Martinez-Naharro, Cristina Quarta, Philip N. Hawkins

ORCID

, Ashutosh D. Wechalekar

A 24‐year experience of autologous stem cell transplantation for light chain amyloidosis patients in the United Kingdom

Download from onlinelibrary.wiley.com

This paper is made freely available by the publisher.

Richa Manwani

ORCID

, Shameem Mahmood, Sajitha Sachchithanantham, Helen J. Lachmann, Julian D. Gillmore, Kwee Yong

ORCID

, Neil Rabin, Rakesh Popat

ORCID

, Charalampia Kyriakou, Sarah Worthington, Faye Sharpley

ORCID

, Mark Smith, Raakhee Shah, Simon Cheesman, Philip N. Hawkins

ORCID

and 1 other authors

Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy

Download from api.wiley.com

This paper was not found in any repository, but could be made available legally by the author.

2018 Faye A. Sharpley

ORCID

, Richa Manwani

ORCID

, Shameem Mahmood, Sajitha Sachchithanantham, Helen Lachmann, Julian Gilmore, Carol Whelan, Phillip Hawkins

ORCID

, Ashutosh Wechalekar

Real world outcomes of pomalidomide for treatment of relapsed light chain amyloidosis

Upload

Missing publications? Search for publications with a matching author name.